Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 4401 - 4425 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Diacylglycerophosphoinositolglycans LMGP15010145
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/18:1(9Z))
126457513 1360.715608 C64H113O28P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AU02
  • Fucalpha1-2Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260325 1359.812604 C66H121NO27
Gangliosides LMSP0601AM01
  • GM2(d18:1/16:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262060 141459 1355.792537 C65H117N3O26
Gangliosides LMSP0601EK01
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262828 1355.792537 C65H117N3O26
Diacylglycerophosphoinositolglycans LMGP15010114
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/18:0)
126457482 1352.746908 C63H117O28P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN04
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260591 1351.870392 C68H125N3O23
Diacylglycerophosphoinositolglycans LMGP15010115
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/18:1(9Z))
126457483 1350.731258 C63H115O28P
Diacylglycerophosphoinositolglycans LMGP15010120
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/18:0)
126457488 1350.731258 C63H115O28P
LMSL03001295
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R-nonamethyl)-19-hydroxy-hexatriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/36:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH))
126457736 1349.012427 C75H144O17S
Diacylglycerophosphoinositolglycans LMGP15010121
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/18:1(9Z))
126457489 1348.715608 C63H113O28P
Diacylglycerophosphoinositolglycans LMGP15010126
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/18:0)
126457494 1348.715608 C63H113O28P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AM01
  • Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260260 1347.776219 C64H117NO28
Diacylglycerophosphoinositolglycans LMGP15010127
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/18:1(9Z))
126457495 1346.699958 C63H111O28P
Gangliosides LMSP0601DC02
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262573 1342.797288 C65H118N2O26
Gangliosides LMSP0601DG02
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • KDN-GM2(d18:1/18:0)
44262605 1342.797288 C65H118N2O26
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB05
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Globoside I/Cytolipin K(d18:1/24:0)
44260176 1338.875143 C68H126N2O23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AS05
  • GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260312 1338.875143 C68H126N2O23
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AB05
  • Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • asialo-GM1(d18:1/24:0)
44260496 1338.875143 C68H126N2O23
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AB05
  • Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • iso-LM1(d18:1/24:0)
44260624 1338.875143 C68H126N2O23
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AA05
  • Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • nLc4Cer(d18:1/24:0)
70699269 1338.875143 C68H126N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AP05
  • Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261936 1338.875143 C68H126N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR05
  • Cytolipin R(d18:1/24:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261576 1338.875143 C68H126N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AT05
  • GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261592 1338.875143 C68H126N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BF05
  • Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261672 1338.875143 C68H126N2O23
Diacylglycerophosphoinositolglycans LMGP15010108
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/18:0)
126457476 1338.731258 C62H115O28P

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024